New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
Last year, 662 people in Belgium were diagnosed with the HIV virus that may cause the disease AIDS. That’s a slight increase ...
The number of new HIV infections in the Netherlands is expected to increase in the coming years, ending a long-running ...
LGBTQ Nation on MSN
U.S. ships groundbreaking HIV drug to Africa, but slashed funding threatens progress
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
In the early 1980s, men and women in the prime of their lives began arriving at Walter Reed Medical Center, wrecked by a disease for which we had no name, ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...
Despite Uganda's steady progress in reducing HIV infections and AIDS-related deaths, men remain disproportionately affected due to low uptake of antiretroviral treatment (ARVs), the Uganda AIDS ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
"I was scared and terrified because I was still very young when I received the news. What else was going to save me if the medicines that are supposed to treat me are failing?" wonders Brandon Jaka, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results